Researchers are focusing on retinal prosthetics owing to relative ease of access to retina for surgery. Retina contains two types of photoreceptors: rods and cones. Presence of Retinitis Pigmentosa (RP), Age-Related Macular Degeneration (AMD), or choroideremia may increase the risk of blindness as the disease progresses. Currently, retinal implants are approved for the treatment of RP and end-stage AMD. According to Foundation Fighting Blindness, RP causes blindness in around 1.5 million people in the world. Similarly, National Eye Institute (NIE), department of National Institute of Health (NIH), states that the number of people suffering from AMD was 2.1 million in 2010 and is expected to double to reach around 5.4 million in 2050 in the U.S. The table below depicts growth of AMD patients by race

Chapter 1 Executive Summary 

Chapter 2 Research Methodology 

Chapter 3 Market Variables, Trends & Scope

Chapter 4 Device Type Estimates & Trend Analysis

Chapter 5 Regional Estimates & Trend Analysis, by Device Type 

Chapter 6 Competitive Landscape